Department of Cardiology, Erasmus Medical Center, Office Ba 308, Postbus 2040, Rotterdam 3000 CA, The Netherlands
Department of Obstetrics and Gynaecology, Erasmus Medical Center, Rotterdam, The Netherlands.
Eur Heart J. 2015 Jul 14;36(27):1728-34, 1734a-1734b. doi: 10.1093/eurheartj/ehv141. Epub 2015 Apr 29.
Contraceptive counselling should begin early in females with heart disease, preferably directly after the start of menstruation. In coming to a decision about the method of contraception, the following issues should be considered: (i) the risk of pregnancy for the mother and the consequences of an unplanned pregnancy; (ii) the risks of the contraceptive method; (iii) failure rates; (iv) the non-contraceptive benefits; (v) the availability; (vi) the individual's preferences; (vii) protection against infection; and (viii) costs. In some women with heart disease, the issues may be complex and require the input of both a cardiologist and an obstetrician (or other feto-maternal expert) to identify the optimal approach. No studies have been performed in women with heart disease to investigate the relative risks and benefits of different contraceptive methods.
避孕咨询应在患有心脏病的女性中尽早进行,最好在月经初潮后直接进行。在决定避孕方法时,应考虑以下问题:(i)母亲怀孕的风险和意外怀孕的后果;(ii)避孕方法的风险;(iii)失败率;(iv)非避孕效益;(v)可用性;(vi)个人偏好;(vii)预防感染;和(viii)成本。在某些患有心脏病的女性中,这些问题可能很复杂,需要心脏病专家和产科医生(或其他胎儿-产妇专家)共同参与,以确定最佳方法。目前还没有针对心脏病女性的研究来调查不同避孕方法的相对风险和益处。